We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWO icon
501
iShares Russell 2000 Growth ETF
IWO
$14.3B
$360K 0.01%
2,621
-500
-16% -$67.5K
DBA icon
502
Invesco DB Agriculture Fund
DBA
$1.23B
$356K 0.01%
16,109
-241
-1% -$5.14K
VNQI icon
503
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
$351K 0.01%
6,493
+467
+8% +$25.2K
EV
504
DELISTED
Eaton Vance Corp.
EV
$351K 0.01%
+9,920
New +$348K
TRV icon
505
Travelers Companies
TRV
$79B
$350K 0.01%
2,943
-200
-6% -$22.6K
FLTX
506
DELISTED
Fleetmatics Group PLC
FLTX
$350K 0.01%
8,084
-6,940
-46% -$277K
MCS icon
507
Marcus Corp
MCS
$859M
$349K 0.01%
16,535
-6,645
-29% -$131K
CAJ
508
DELISTED
Canon, Inc.
CAJ
$345K 0.01%
12,063
UPM
509
DELISTED
UPM-KYMMRME ADR (REPR ORD SHS)
UPM
$345K 0.01%
18,908
MDLZ icon
510
Mondelez International
MDLZ
$79.4B
$344K 0.01%
7,557
TIP icon
511
iShares TIPS Bond ETF
TIP
$14.5B
$340K 0.01%
2,915
IPXL
512
DELISTED
Impax Laboratories, Inc.
IPXL
$340K 0.01%
11,785
+125
+1% +$4.07K
FE icon
513
FirstEnergy
FE
$28.1B
$338K 0.01%
9,689
-8,245
-46% -$279K
CRL icon
514
Charles River Laboratories
CRL
$11.2B
$336K 0.01%
+4,070
New +$335K
LQD icon
515
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.2B
$336K 0.01%
2,735
AMP icon
516
Ameriprise Financial
AMP
$48.3B
$335K 0.01%
3,729
-7,610
-67% -$735K
PPG icon
517
PPG Industries
PPG
$24.7B
$333K 0.01%
3,200
SI
518
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$331K 0.01%
3,247
UFS
519
DELISTED
DOMTAR CORPORATION (New)
UFS
$330K 0.01%
9,425
+60
+0.6% +$2.31K
SHM icon
520
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$329K 0.01%
6,700
AKAM icon
521
Akamai
AKAM
$16.6B
$325K 0.01%
5,804
DBE icon
522
Invesco DB Energy Fund
DBE
$90.2M
$324K 0.01%
25,795
-969
-4% -$11.4K
KYNB
523
Kyntra Bio
KYNB
$27.4M
$324K 0.01%
789
+209
+36% +$95.7K
EPD icon
524
Enterprise Products Partners
EPD
$82.2B
$317K 0.01%
+10,820
New +$290K
ITW icon
525
Illinois Tool Works
ITW
$82.2B
$317K 0.01%
3,040
-300
-9% -$31.4K

Similar funds

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.